Research On American Pharmaceutical Patent Linkage System And Enlightenment To China

The original research medicine applied the original patented technology to the drug manufacturing,which greatly improved the medical level of human beings.Generic drug products can break the monopoly of original research drug products in the market to a certain extent,on the other hand,they can also improve the availability of drugs to the public.When applying for registration,the manufacturer of generic drugs shall analyze whether the patented products are similar in technology and the status of rights of patented products,and make specific plans for its own products to avoid and solve the disputes over patent rights.To this end,in the 1980 s,the United States established a system for linking drugs to patents.The United States drug patent link system follows the kernel of TRIPS-Plus rule,and tends to protect the rights of original drug manufacturers.In accordance with the specific situation of the technical level of the domestic pharmaceutical industry,legislation and administrative management should be carried out in China to formulate the system planning and design that keeps pace with The Times and is practical,so as to essentially coordinate the relationship between promoting the continuous innovation of original research drugs and stimulating the enthusiasm of generic drug production.